The use of the three established methods for isolation of CSCs followed by in vitro self renewal analysis by mammosphere formation studies have thus brought out the ALDH1+ phenotype as the best candidate putative stem cell marker for BRCA1-defective breast cancer cells. This evidence concerns the gene ALDH1A1 and breast carcinoma.